Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence : A cautionary tale
Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved..
We performed a retrospective screening of 428 serum samples for anti-SARS-CoV-2 immunoglobulin during a period of low prevalence. Employing two different serological tests yielded discrepant results for 10 samples; highlighting an increased risk of potential false positive results and the need for further confirmatory testing before publication of data.
| Errataetall: |
CommentOn: J Infect. 2021 May;82(5):186-230. - PMID 33271171 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
The Journal of infection - 83(2021), 1 vom: 01. Juli, Seite 119-145 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bird, Paul William [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 24.06.2021 Date Revised 24.06.2021 published: Print-Electronic CommentOn: J Infect. 2021 May;82(5):186-230. - PMID 33271171 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.03.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323007058 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323007058 | ||
| 003 | DE-627 | ||
| 005 | 20231225183238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.03.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1076.xml |
| 035 | |a (DE-627)NLM323007058 | ||
| 035 | |a (NLM)33744303 | ||
| 035 | |a (PII)S0163-4453(21)00124-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bird, Paul William |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retrospective serosurveillance for anti-SARS-CoV-2 immunoglobulin during a time of low prevalence |b A cautionary tale |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.06.2021 | ||
| 500 | |a Date Revised 24.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2021 May;82(5):186-230. - PMID 33271171 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a We performed a retrospective screening of 428 serum samples for anti-SARS-CoV-2 immunoglobulin during a period of low prevalence. Employing two different serological tests yielded discrepant results for 10 samples; highlighting an increased risk of potential false positive results and the need for further confirmatory testing before publication of data | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Low prevalence | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Serological testing | |
| 650 | 7 | |a Immunoglobulins |2 NLM | |
| 700 | 1 | |a Holmes, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Fletcher, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Badhwar, Vinay |e verfasserin |4 aut | |
| 700 | 1 | |a Toovey, Oliver |e verfasserin |4 aut | |
| 700 | 1 | |a Tang, Julian Wei-Tze |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 1 vom: 01. Juli, Seite 119-145 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2021 |g number:1 |g day:01 |g month:07 |g pages:119-145 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.03.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2021 |e 1 |b 01 |c 07 |h 119-145 | ||